Response unit called as Salisbury Hospital declares “major incident”

Salisbury District Hospital declared a “major incident” on Monday 5 March, after two patients were exposed to what is believed to be an opioid. The fire service was called to decontaminate the hospital’s Accident & Emergency unit, as paramedics treated the casualties.

Emergency personnel arrived to the scene, wearing full-body hazardous materials protective and an incident response unit was on site.

It followed an incident hours earlier in which a man and a woman were exposed to a substance in the city centre.

A spokesman for Salisbury NHS Foundation Trust said: "We are currently dealing with a major incident involving a small number of casualties, with a multi-agency response. It is under 10 people, but I cannot say any more at the moment.

"People with outpatient appointments in other areas of the hospital can still come in as planned, but we are asking people not to come to the Accident and Emergency department unless it is an emergency."

Note: This story was updated on 26 April 2018 to remove suggestion (which was widely speculated and reported at the time of writing) that the substance found was fentanyl.

 

Other news

Upcoming Events

CSC Annual Scientific Meeting

Worsley Park Marriott Hotel and Country Club
1st and 2nd April

ebme 2019

Arena MK, Milton Keynes
3rd and 4th April 2019

BSA Annual Conference 2019: Translating Research into Practice

Molineux Stadium, Wolverhampton
Wednesday 5th June

BSG Annual Meeting 2019

Glasgow
Monday 17th June to Thursday 20th June 2019

AfPP Residential 2019

York University
8th to the 11th August

Latest Issue

Clinical Services Journal

Clinical Services Journal

Mar 2019

Endoscope decontamination

Register now to apply for regular copies of Clinical Services Journal and free access to premium content, as well as our regular newsletters.

CSJ Supplements

CSJ Supplements

Dec 2018

‘Clean Between’ – renewing the focus on infection prevention

Register now to apply for regular copies of CSJ Supplements and free access to premium content, as well as our regular newsletters.